Extreme Environment Streptomyces: Potential Sources for New Antibacterial and Anticancer Drug Leads?
Antimicrobial resistance (AR) is recognized as one of the greatest threats to public health and in global concern. Consequently, the increased morbidity and mortality, which are associated with multidrug resistance bacteria, urgently require the discovery of novel and more efficient drugs. Conversel...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | International Journal of Microbiology |
Online Access: | http://dx.doi.org/10.1155/2019/5283948 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832555204463034368 |
---|---|
author | Periyasamy Sivalingam Kui Hong John Pote Kandasamy Prabakar |
author_facet | Periyasamy Sivalingam Kui Hong John Pote Kandasamy Prabakar |
author_sort | Periyasamy Sivalingam |
collection | DOAJ |
description | Antimicrobial resistance (AR) is recognized as one of the greatest threats to public health and in global concern. Consequently, the increased morbidity and mortality, which are associated with multidrug resistance bacteria, urgently require the discovery of novel and more efficient drugs. Conversely, cancer is a growing complex human disease that demands new drugs with no or fewer side effects. Most of the drugs currently used in the health care systems were of Streptomyces origin or their synthetic forms. Natural product researches from Streptomyces have been genuinely spectacular over the recent years from extreme environments. It is because of technical advances in isolation, fermentation, spectroscopy, and genomic studies which led to the efficient recovering of Streptomyces and their new chemical compounds with distinct activities. Expanding the use of the last line of antibiotics and demand for new drugs will continue to play an essential role for the potent Streptomyces from previously unexplored environmental sources. In this context, deep-sea, desert, cryo, and volcanic environments have proven to be a unique habitat of more extreme, and of their adaptation to extreme living, environments attribute to novel antibiotics. Extreme Streptomyces have been an excellent source of a new class of compounds which include alkaloids, angucycline, macrolide, and peptides. This review covers novel drug leads with antibacterial and cytotoxic activities isolated from deep-sea, desert, cryo, and volcanic environment Streptomyces from 2009 to 2019. The structure and chemical classes of the compounds, their relevant bioactivities, and the sources of organisms are presented. |
format | Article |
id | doaj-art-cbf879f88b3047cabc1d6637673f5766 |
institution | Kabale University |
issn | 1687-918X 1687-9198 |
language | English |
publishDate | 2019-01-01 |
publisher | Wiley |
record_format | Article |
series | International Journal of Microbiology |
spelling | doaj-art-cbf879f88b3047cabc1d6637673f57662025-02-03T05:49:21ZengWileyInternational Journal of Microbiology1687-918X1687-91982019-01-01201910.1155/2019/52839485283948Extreme Environment Streptomyces: Potential Sources for New Antibacterial and Anticancer Drug Leads?Periyasamy Sivalingam0Kui Hong1John Pote2Kandasamy Prabakar3Department F.-A. Forel for Environmental and Aquatic Sciences and Institute of Environmental Sciences, School of Earth and Environmental Sciences, Faculty of Science, University of Geneva, Uni Carl Vogt, 66 Boulevard Carl-Vogt, CH-1211 Geneva 4, SwitzerlandKey Laboratory of Combinatorial Biosynthesis and Drug Discovery (Wuhan University), Ministry of Education, Wuhan University School of Pharmaceutical Sciences, Wuhan 430071, ChinaDepartment F.-A. Forel for Environmental and Aquatic Sciences and Institute of Environmental Sciences, School of Earth and Environmental Sciences, Faculty of Science, University of Geneva, Uni Carl Vogt, 66 Boulevard Carl-Vogt, CH-1211 Geneva 4, SwitzerlandPostgraduate and Research Department of Zoology, Jamal Mohamed College, Tiruchirappalli 620020, Tamil Nadu, IndiaAntimicrobial resistance (AR) is recognized as one of the greatest threats to public health and in global concern. Consequently, the increased morbidity and mortality, which are associated with multidrug resistance bacteria, urgently require the discovery of novel and more efficient drugs. Conversely, cancer is a growing complex human disease that demands new drugs with no or fewer side effects. Most of the drugs currently used in the health care systems were of Streptomyces origin or their synthetic forms. Natural product researches from Streptomyces have been genuinely spectacular over the recent years from extreme environments. It is because of technical advances in isolation, fermentation, spectroscopy, and genomic studies which led to the efficient recovering of Streptomyces and their new chemical compounds with distinct activities. Expanding the use of the last line of antibiotics and demand for new drugs will continue to play an essential role for the potent Streptomyces from previously unexplored environmental sources. In this context, deep-sea, desert, cryo, and volcanic environments have proven to be a unique habitat of more extreme, and of their adaptation to extreme living, environments attribute to novel antibiotics. Extreme Streptomyces have been an excellent source of a new class of compounds which include alkaloids, angucycline, macrolide, and peptides. This review covers novel drug leads with antibacterial and cytotoxic activities isolated from deep-sea, desert, cryo, and volcanic environment Streptomyces from 2009 to 2019. The structure and chemical classes of the compounds, their relevant bioactivities, and the sources of organisms are presented.http://dx.doi.org/10.1155/2019/5283948 |
spellingShingle | Periyasamy Sivalingam Kui Hong John Pote Kandasamy Prabakar Extreme Environment Streptomyces: Potential Sources for New Antibacterial and Anticancer Drug Leads? International Journal of Microbiology |
title | Extreme Environment Streptomyces: Potential Sources for New Antibacterial and Anticancer Drug Leads? |
title_full | Extreme Environment Streptomyces: Potential Sources for New Antibacterial and Anticancer Drug Leads? |
title_fullStr | Extreme Environment Streptomyces: Potential Sources for New Antibacterial and Anticancer Drug Leads? |
title_full_unstemmed | Extreme Environment Streptomyces: Potential Sources for New Antibacterial and Anticancer Drug Leads? |
title_short | Extreme Environment Streptomyces: Potential Sources for New Antibacterial and Anticancer Drug Leads? |
title_sort | extreme environment streptomyces potential sources for new antibacterial and anticancer drug leads |
url | http://dx.doi.org/10.1155/2019/5283948 |
work_keys_str_mv | AT periyasamysivalingam extremeenvironmentstreptomycespotentialsourcesfornewantibacterialandanticancerdrugleads AT kuihong extremeenvironmentstreptomycespotentialsourcesfornewantibacterialandanticancerdrugleads AT johnpote extremeenvironmentstreptomycespotentialsourcesfornewantibacterialandanticancerdrugleads AT kandasamyprabakar extremeenvironmentstreptomycespotentialsourcesfornewantibacterialandanticancerdrugleads |